beta-cyclodextrin-benzaldehyde (CDBA)

01/01/2008 - "The present study suggests that CDBA induces autophagic cell death in cancer cell lines."
01/01/2008 - "CDBA showed slightly higher cytotoxicity against human tumor cell lines, as compared to normal cells, with a tumor-specificity index of 2.2. "
01/01/2008 - "Tumor-specific cytotoxicity and type of cell death induced by beta-cyclodextrin benzaldehyde inclusion compound."
01/01/1991 - "However, the most significant effect of CDBA might be the maintenance of the Lyt-2+ cell level in the spleen cells from tumor-bearing mice. "
01/01/1991 - "In a LAK cytotoxicity assay in vitro, the augmentative effect of CDBA was strongly exerted against spleen cells originating from 2-week-tumor-bearing mice, rather than those from normal mice or mice that had born tumors for 5 weeks. "

03/01/1988 - "[Inhibition of pulmonary metastases in mice by beta-cyclodextrin-benzaldehyde]."
07/01/1987 - "In spontaneous metastasis that was induced by sc injection of 3 X 10(6) RCT (+) cells, the inhibition of metastasis was also observed in the mice treated with CDBA (5 mg/day) in the same manner as described above. "
01/01/1986 - "Inhibition of experimental pulmonary metastasis in mice by beta-cyclodextrin-benzaldehyde."
03/01/1988 - "And also, daily treatment of CDBA prolonged the survival time of the tumor bearing mice in both experimental and spontaneous metastasis studies. "
03/01/1988 - "These data suggest that CDBA improve the survival time of tumor bearing mice through the inhibition of the lung metastasis."

07/01/1987 - "Inhibition of experimental and spontaneous pulmonary metastasis of murine RCT (+) sarcoma by beta-cyclodextrin-benzaldehyde."
01/01/1991 - "We investigated the effect of beta-cyclodextrin-benzaldehyde (CDBA) on lymphokine-activated killer (LAK) cell activity of spleen cells from normal or RCT(+)H-2(+)-sarcoma-bearing C3H/He mice. "

05/28/1965 - "EXPERIMENTAL RESULTS FROM EXPOSURE OF CLOUDMAN S-91 MELANOMA IN THE CDBA/2F1 HYBRID MOUSE TO NEODYMIUM OR RUBY LASER RADIATION."

01/01/2008 - "Human myelogenous leukemia cell lines (HL-60, ML-1, KG-1) were the most sensitive to CDBA, followed by human oral squamous cell carcinoma (HSC-2, HSC-3, HSC-4) and human glioblastoma (T98G, U87MG). "